Yasushi Murakami1, Hideo Saka2, Masahide Oki2. Show Affiliations » 1. Department of Respiratory Medicine, Nagoya Medical Center, Nagoya, Japan. Electronic address: konyasu222@gmail.com. 2. Department of Respiratory Medicine, Nagoya Medical Center, Nagoya, Japan.
Abstract
Entities: Chemical Disease
Mesh: See more » Anaplastic Lymphoma KinaseAntineoplastic Agents/therapeutic useBone Neoplasms/secondaryBrain Neoplasms/secondaryCarcinoma/geneticsCarcinoma/secondaryCarcinoma/therapyCrizotinibFatal OutcomeGene RearrangementHumansLiver Neoplasms/secondaryLung Neoplasms/geneticsLung Neoplasms/pathologyLung Neoplasms/therapyMaleMiddle AgedPyrazoles/therapeutic usePyridines/therapeutic useReceptor Protein-Tyrosine Kinases/geneticsRetreatment
Substances: See more » Antineoplastic AgentsPyrazolesPyridinesCrizotinibALK protein, humanAnaplastic Lymphoma KinaseReceptor Protein-Tyrosine Kinases
Year: 2015 PMID: 25898961 DOI: 10.1097/JTO.0000000000000450
Source DB: PubMed Journal: J Thorac Oncol ISSN: 1556-0864 Impact factor: 15.609